Effortless Office Enterprises, LLC. Notifies Individuals of Data Security Incident 
Modernizing Medicine Announces Brian Boyd as Chief Revenue Officer
Mr. Boyd will oversee the sales organization while continuing to build on the health IT company’s rapid growth BOCA RATON,...
Boyd Corporation Announces ISO 13485:2016 Certification of Facility in Southern Asia
Boyd Expands Its Medical Quality Management Systems for Medical Devices in South Asia with ISO 13485:2016 Certification PLEASANTON, Calif.--(BUSINESS WIRE)--#Aavid--Boyd...
GE Healthcare Selects InTouch Health to Provide Virtual Communication Capabilities for its Virtual Care Solution: Mural
Expanded collaboration between two leading health technology companies further illustrates market demand for integrated virtual care solutions SANTA BARBARA, Calif.--(BUSINESS...
Medsphere Adds CloudMedx Artificial Intelligence to CareVue EHR Platform
Machine learning and natural language processing tools enable CareVue clients to improve care through tailored, actionable, agile insights CARLSBAD, Calif.--(BUSINESS...
Alzamend Neuro™ Announces First Appointment to Scientific Advisory Board
Appoints Dr. Thomas Wisniewski, Leading Pioneer in Alzheimer’s Disease TAMPA, Fla.--(BUSINESS WIRE)--#Alzamend--Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today...
ProAssurance Corporation Announces Dates for Second Quarter 2019 Earnings Release and Conference Call
BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended June 30, 2019 after the close of normal...
Vapotherm to Report Second Quarter 2019 Financial Results
EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm”), a global medical technology company focused on the development and commercialization of its...
Intellipharmaceutics International Inc. Announces $10,000,000 Equity Financing Commitment
TORONTO, ON / ACCESSWIRE / July 8, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) ("Intellipharmaceutics" or the...
MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of CD47-SIRP alpha Signaling in Immuno-Oncology
PLANEGG, MUNICH and HALLE (SAALE), GERMANY / ACCESSWIRE / July 8, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment;...
Indo Global Exchange(s) Pte Ltd Announces Shareholder Update
New CEO Introduces Operational Strategy CLOVERDALE, CA / ACCESSWIRE / July 8, 2019 / Indo Global Exchange(s) Pte Ltd (USOTC:...
Advanzeon Solutions, Inc.’s Wholly Owned Subsidiary’s SleepMaster Solutions (TM) Sleep Apnea Program has been Selected by All Aboard America! for its Drivers and Employees
TAMPA, FL / ACCESSWIRE / July 8, 2019 / Advanzeon Solutions, Inc. (OTC PINK: CHCR) ("Advanzeon") announced today that its...
Avinger Announces Commercial Launch of Ocelot in Australia
First Patients Treated Successfully in Australia with Image-Guided CTO-Crossing Device REDWOOD, CA / ACCESSWIRE / July 8, 2019 / Avinger,...
Sterna Biologicals Strengthens Management Team To Progress Towards Phase IIb Development
Industry veteran Dr. Marion Wencker strengthens sterna's management team as consulting CMO Financial expert Dr. Thomas Klaue recently joined sterna...
Aytu BioScience Announces Publication of Clinical Study Results Demonstrating Effectiveness of Natesto(R) Regardless of Patients’ Baseline Hypogonadism Severity
First Natesto Study to Demonstrate Efficacy in Severely Hypogonadal Patients ENGLEWOOD, CO / ACCESSWIRE / July 8, 2019 / Aytu...
Savonix Announces Publication in Cognition, Brain, Behavior
SAN FRANCISCO--(BUSINESS WIRE)--Savonix, a global leader in digital tests for cognitive health, announced today that the company has published a...
Evotec And Venture Capital Consortium Form ‘Breakpoint Therapeutics Gmbh’
PORTFOLIO OF DRUG DISCOVERY PROJECTS TARGETING DNA DAMAGE RESPONSES ("DDR"), A HIGHLY PROMISING APPROACH TO TREAT CANCER PATIENTS BREAKPOINT THERAPEUTICS...
EastWest Bioscience Reports Third Quarter 2019 Financial Results
VANCOUVER, BC / ACCESSWIRE / July 4, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) expands on its...
Senseonics Announces Equity Grants To Employees Under Inducement Plan
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a...
Ad hoc: MorphoSys Increases Financial Guidance for 2019 Following a Milestone Payment for Antibody Otilimab (MOR103/GSK3196165) by GSK
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / July 3, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX &...
MorphoSys’s Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab (MOR103/GSK3196165) in Rheumatoid Arthritis; MorphoSys Updates its Financial Guidance for 2019
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / July 3, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX &...